Domestic pharmaceutical equipment is broken and the future market growth can be expected

[Pharmaceutical Network Market Analysis] The domestic pharmaceutical equipment industry, which is accelerating the pace of import substitution, is showing stronger development resilienc.
According to data previously released by CIC, the scale of the global pharmaceutical equipment industry currently exceeds 500 billion yuan, and it will exceed 700 billion yuan in 2025.In the Chinese market, its scale has approached 100 billion yuan, and it is expected to reach 200 billion yuan by 2025. Pharmaceutical equipment (Source: Pharmaceutical Network) The epidemic has accelerated the process of import substitution of domestic pharmaceutical machine.
Due to the delayed delivery of imported equipment, pharmaceutical companies have turned their attention to domestic powerful domestic pharmaceutical machine manufacturer.
Compared with the past, domestic pharmaceutical machine enterprises have continuously strengthened technical research and increased investment in research and development in recent years, and the performance of some equipment has been comparable to imported equipmen.
In addition, domestic pharmaceutical machine enterprises have the advantages of fast delivery and high after-sales service leve.
Leading companies including Chutian Technology and Tofflon are actively embracing new opportunities, and orders have grown significantl.
It is not difficult to speculate that in the post-epidemic era, the slow import substitution of domestic medicine machines will chang.
At the same time, more medicine machine products are expected to enter the overseas market and increase their recognition and share in overseas market.
The growth of the domestic medicine machine market can be expected in the futur.
It is worth mentioning that how to seize the opportunities and challenges brought about by the changes in the pharmaceutical machine market is a problem that pharmaceutical machine people have to fac.
Compared with imported medicine machines, domestic medicine machines have a late start and weak technology, but it is undeniable that after years of development and technology accumulation, coupled with the promotion of new medical reform policies such as consistency evaluation, centralized procurement, and medical insurance in recent years , forcing the upstream pharmaceutical equipment to speed up the transformation and upgrading, and now the level of domestic pharmaceutical machines is constantly improvin.
At the same time, the policy side and the demand side also bring more possibilities to the pharmaceutical machine industr.
Among them, on the policy side, the high-end pharmaceutical equipment industry is receiving policy encouragement and support, and the gradual improvement of pharmaceutical industry standards and stricter supervision force the industry to update and upgrade in the direction of automation and intelligenc.
The "mother machine" will play a more important role in improving the level of domestic pharmaceutical.
On the demand side, with the intensified aging of the population and the continuous upgrading of consumption, the rapid development of markets such as biological drugs, innovative drugs and pharmaceutical outsourcing will drive the expansion of the market demand for pharmaceutical equipmen.
However, the domestic pharmaceutical equipment industry still faces some challenge.
The main challenges include low industry concentration, serious homogenization competition, and talent shortag.
The concentration of the pharmaceutical equipment industry has always been relatively lo.
At present, there are only a few listed companies in the market, such as Chutian and Tofflo.
The homogeneous competition of small and medium-sized enterprises is serious, and it is inevitable to fall into a low-level low-price wa.
The reason why the overall industry level of domestic pharmaceutical machines is not high and the lack of innovation is mainly related to the shortage of talent.
The pharmaceutical equipment industry is a complex disciplin.
It is necessary to understand both medicine and equipmen.
It also requires industry technology innovation developers to keep up with the trend of intelligence and automatio.
Currently, there is a shortage of compound talents in the market that can meet the needs of pharmaceutical machine companie.
, and most of them are mainly based on self-cultivation by enterprise.
In the future, how to make up for the shortcomings of talents in the industry is a major challeng.
Faced with a market space of 100 billion yuan, pharmaceutical machine companies need both internal and external trainin.
They need a better environment and policy support externall.
Internally, they need to strengthen the core competitiveness of enterprise.
On the one hand, the pharmaceutical equipment industry needs more support from favorable policie.
For example, in terms of talents, more measures can be given to strengthen personnel training and improve the status and treatment of pharmaceutical machinery personnel; in terms of R&D innovation, more incentives for pharmaceutical machinery enterprises can be introduce.
Innovation policies, and support for R&D investment in corporate fund.

On the other hand, pharmaceutical machine companies have cultivated "hard core" for domestic demand, including attaching importance to talent team strength, strengthening R&D innovation, et.
, and under the trend of intelligence, automation, and continuity, they must seize new directions and continue to transform and upgrad.
At the same time, energy saving and consumption reduction is also the development trend of the pharmaceutical machine industr.
Pharmaceutical machine companies need to actively respond to the call and invest in the development and research of environmentally friendly pharmaceutical machines to meet the new needs of the marke.
In addition, in terms of internationalization of the layout, on the basis of excellent equipment performance, fast delivery, and timely after-sales service, pharmaceutical machine companies need to continue to improve service levels, and in-depth understanding of the target market's policies, supervision and other aspects in order to better into the target marke.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyon.